Advanced Search
Search
  
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire

Other News Releases in Health Care & Hospitals

Congressman Fattah: Thanks to Specter, Casey for a Major Step Along History's Path

Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure

Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill

Other News Releases in FDA Approval

American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products

Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

See more news releases in: Health Care & Hospitals, Medical Pharmaceuticals, FDA Approval

 

Zydus Pharmaceuticals (USA) Inc. Announces FDA Final Approval for the Generic Version of Topamax(R) Tablets

PRINCETON, N.J., March 27 /PRNewswire/ -- Zydus Pharmaceuticals announced today that it has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Topiramate Tablets USP, 25mg, 50mg, 100mg, and 200mg. This product is available for immediate shipment.

Topiramate tablets are indicated as an initial monotherapy in patients 10 years old or older with partial onset or primary generalized tonic-clonic seizures. It is also indicated as an adjunctive therapy for adults and pediatric patients ages 2 - 16 with partial onset seizures, or primary generalized tonic-clonic seizures, and in patients 2 years of age or older with seizures associated with Lennox-Gastaut syndrome. Topiramate tablets are the generic version of Ortho-McNeil-Janssen's Topamax(R) Tablets and according to Wolters Kluwer Health (formerly NDC Health) that product had sales over $3.2 billion for the 12 months ending February 28, 2009.

Zydus Pharmaceuticals (USA) Inc., located in Princeton, N.J., is the U.S. division of Cadila Healthcare. Cadila Healthcare is India's 4th largest pharmaceutical company and has a presence in over 50 countries worldwide. This is Zydus Pharmaceutical's 42nd tentative or final approval over the last four years. For more information on Zydus Pharmaceuticals please visit our website at www.zydususa.com.

SOURCE Zydus Pharmaceuticals (USA) Inc.